In contrast, G6PD testing to inform malaria case management using primaquine has typically not been possible due to the complexity of current G6PD test methods, which are not compatible with the remote and under-resourced clinical and laboratory settings where a majority of malaria patients seek care (Figure 1). Here, G6PD is linked to malaria.